EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Future of Cancer Diagnosis and Treatment: Unlocking the Power of Biomarkers and Personalized Molecular-Targeted Therapies

Getnet Molla, Molalegne Bitew

Journal of Molecular Pathology · 28.08.2025 · 6 (3) · 20

DOI: 10.3390/jmp6030020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Pathology, online erschienen am 28.08.2025. Verfasst von Getnet Molla und 1 weiteren Autor:innen. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer remains a leading global health challenge, with conventional diagnostic and treatment methods often lacking precision and adaptability. This review explores transformative advancements that are reshaping oncology by addressing these limitations. It begins with an overview of cancer’s complexity, emphasizing the shortcomings of conventional tools such as imaging and chemotherapy, which frequently fail to deliver targeted care. The discussion then shifts to biomarkers, which represent a groundbreaking frontier in early detection, enabling the identification of unique biological signatures that signal the presence of cancer with heightened sensitivity. Building on this foundation, the review examines personalized molecular therapies, which target the specific genetic and molecular vulnerabilities of tumors. These therapies not only enhance treatment efficacy but also minimize adverse effects, offering patients improved outcomes and quality of life. By integrating biomarker-driven diagnostics with tailored therapeutic strategies, a new paradigm of precision oncology emerges, bridging the gap between early detection and effective intervention. Real-world case studies highlight both successes, such as significantly improved survival rates, and persistent challenges, including accessibility and cost barriers. Looking ahead, the review outlines pathways by which to scale these innovations, emphasizing the critical need for robust infrastructure, sustained research investment, and equitable healthcare policies. It concludes by envisioning a future where biomarkers and personalized therapies converge to redefine cancer care, offering earlier detection, precise interventions, and better patient experiences. This work underscores the urgency of adopting cutting-edge approaches to overcome cancer’s persistent threats, paving the way for a more effective and humane era in oncology.

Zitieren

APA

Molla, G., & Bitew, M. (2025). The Future of Cancer Diagnosis and Treatment: Unlocking the Power of Biomarkers and Personalized Molecular-Targeted Therapies. Journal of Molecular Pathology, 6(3), 20. https://doi.org/10.3390/jmp6030020

Vancouver

Molla G, Bitew M. The Future of Cancer Diagnosis and Treatment: Unlocking the Power of Biomarkers and Personalized Molecular-Targeted Therapies. Journal of Molecular Pathology. 2025;6(3):20. doi:10.3390/jmp6030020

BibTeX
@article{Molla2025,
  author = {Molla, Getnet and Bitew, Molalegne},
  title = {The Future of Cancer Diagnosis and Treatment: Unlocking the Power of Biomarkers and Personalized Molecular-Targeted Therapies},
  journal = {Journal of Molecular Pathology},
  year = {2025},
  volume = {6},
  number = {3},
  pages = {20},
  doi = {10.3390/jmp6030020}
}
Kostenlos starten →